This site is intended for Healthcare Professionals only

Incorrect username and/or password, please try again or click to reset.

AmBisome 50mg Powder for Solution for Infusion - potential lack of sterility assurance

2014-12-17 15:00:38 (11 year(s) ago)

Summary

(Gilead Sciences International Limited) Remaining stocks of affected batches should be quarantined and returned to the original supplier for credit – class 1 action now. (EL (13)A/17)

Read full MHRA article

Respond to this alert

Sign up for your FREE ticket to see PharmData at the Pharmacy Show to see our latest products and features demonstrated live!